Compounds > norfloxacin

norfloxacin and carbon tetrachloride

norfloxacin has been researched along with carbon tetrachloride in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Itoh, T; Mitsumori, K; Moto, M; Sakai, H; Takahashi, M1
Chen, L; Chen, S; Chen, Y; Deng, H; Gao, Z; Gu, Y; Zhang, G; Zhang, W1
Acevedo, J; Brusasco, C; Corradi, F; Fernández, J; Fernández-Varo, G; Gines, P; Mosbah, IB; Navasa, M; Pelosi, P; Ramirez, MJ; Rocco, PR; Seva-Pereira, T; Silva, A; Vila, J1
Bellot, P; Francés, R; García, I; Gimenez, P; Gómez-Hurtado, I; González-Navajas, JM; Guarner, F; Manichanh, C; Ramos, JM; Such, J; Zapater, P1

Other Studies

5 other study(ies) available for norfloxacin and carbon tetrachloride

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
    Toxicology, 2006, May-15, Volume: 222, Issue:3

    Topics: 2-Acetylaminofluorene; Animals; Anti-Infective Agents; Carbon Tetrachloride; Carcinogens; Ciprofloxacin; Glutathione Transferase; Liver; Male; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred F344

2006
Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.
    European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Bifidobacterium; Carbon Tetrachloride; Endotoxemia; Enterobacteriaceae; Enterococcus; Intestines; Lactobacillus; Liver; Liver Cirrhosis, Experimental; Male; Norfloxacin; Probiotics; Rats; Rats, Sprague-Dawley

2010
Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Ascites; Ascitic Fluid; Bacterial Translocation; Carbon Tetrachloride; Cecum; Enterobacteriaceae; Enterobacteriaceae Infections; Free Radical Scavengers; Intestinal Mucosa; Liver Cirrhosis; Malondialdehyde; Norfloxacin; Oxidative Stress; Pentoxifylline; Peritonitis; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2012
Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytokines; Gastrointestinal Microbiome; Inflammation Mediators; Liver Cirrhosis, Experimental; Male; Microbial Viability; Norfloxacin; Rats, Sprague-Dawley; Rifaximin

2018